Whereas a pro-inflammatory role of PCSK9 in atherosclerosis has been suggested, clinical studies did not show a significant reduction of systemic inflammatory biomarkers by PCSK9-antibodies, even in myocardial infarction [30,31]. Here, PCSK9 is linked to myocardial infarction.